Introduction {#Sec1}
============

The International Agency for Research on Cancer (IARC) estimated that worldwide 430,000 people were diagnosed with bladder cancer in 2012, with an age-standardised rate (ASR) of 5.3 per 100,000 people. Incidence of bladder cancer is particularly high in males with 77 % of the cases, ranking it the 7th highest on incidence and 9th highest on mortality. For females it is the 19th highest on incidence and 17th highest on mortality. The incidence of bladder cancer is almost 3 times higher in more developed countries compared to less developed countries (ASR of 9.5 and 3.3 per 100,000 respectively) \[[@CR1]\].

Several genetic polymorphisms have been proposed to be associated with the development of bladder cancer. However, genetic effects can explain 'only' 7 % of the bladder cancer incidence in western populations \[[@CR2]\], and therefore, risk factors related to lifestyle, environmental, and occupational exposures could potentially play an important role in the development of this disease. Over the years, multiple external risk factors have been proposed. Well-established risk factors are tobacco consumption, occupational exposure, such as to aromatic amines and Polycyclic Aromatic Hydrocarbons (PAHs), and infection with *Schistosoma hematobium* \[[@CR3]\]. Whereas smoking is the most important risk factor in developed countries, *S. hematobium* infection accounts for the largest burden in African countries \[[@CR4], [@CR5]\]. Additional suggested risk factors are, amongst others, alcohol consumption, coffee intake, low fruit, and vegetable consumption, low selenium and vitamin E intake, pollution of drinking water, and several medical treatments \[[@CR3], [@CR6]\].

Exposure to some of the key risk factors of bladder cancer has been successfully reduced in the population. For example, the reduction in exposure to aromatic amines seemed to be directly related to a reduction in bladder cancer incidence \[[@CR7]\]. Men are generally more exposed to occupational risk factors of bladder cancer and it is estimated that 7.1 % of the bladder cancer cases in men can be attributed to occupational factors \[[@CR8]\]. Also, the prevalence rates of smoking have been declining significantly over the past decades, although the absolute number of smokers has been increasing due to the growing world population \[[@CR9]\]. Because men smoke more than women, the percentage of cases attributable to smoking is higher in males than in females: 42.8 % (males) versus 25.7 % (females) in Europe, and 34.3 % (males) versus 30.1 % (females) in the United States \[[@CR10]\]. This higher prevalence of smoking among men also explains part of the discrepancy in incidence between men and women \[[@CR11]\]. Despite the reduction in exposure to some risk factors, significant exposure, and thus disease, remains. This means that the burden on the health care system will remain substantial especially when considering that at least 50 % of bladder cancers recur \[[@CR12]\] and long-term monitoring of patients is required, resulting in the highest per patient lifetime costs amongst all cancers \[[@CR13]\]. For example, in the US, the annual cost of care of bladder cancer was estimated to be \$US4 billion. Therefore, primary prevention is paramount, particularly because many of the risk factors are modifiable and therefore preventable.

Prioritising control measures should be evidence-based. To this end, an accessible and comprehensive overview is needed of the modifiable risk factors in the development of bladder cancer, including estimates of public health impact. To our knowledge, no quantitative overview has been published addressing all modifiable risk factors of bladder cancer. Therefore, our aim was to give an overview of the current state of knowledge, at the highest level of evidence, with regard to modifiable lifestyle, environmental, and occupational risk factors for development of bladder cancer by performing a systematic review of meta-analyses (MAs), in combination with a series of meta--meta-analyses (MMAs).

Methods {#Sec2}
=======

This systematic review was registered with PROSPERO (identification number CRD42015023411) \[[@CR14]\]. Where relevant, the publication is written in accordance to the PRISMA guidelines \[[@CR15]\].

Search strategy {#Sec3}
---------------

A systematic literature search was performed up to September 2015 in PubMed, Embase, and the Cochrane database to identify published articles of MAs and pooled analyses describing the association between lifestyle, environmental, and occupational risk factors and the development of bladder cancer. In addition, PROSPERO was searched and authors of registered but not published reviews were contacted. Finally forward and backward referencing of relevant publications was checked for additional publications.

The database was searched using the following search terms: "urinary bladder neoplasms"\[MeSH Terms\], "urinary bladder neoplasms"\[All Fields\], "bladder cancer", combined with systematic\[sb\], meta-analysis\[Title/Abstract\], meta-analysis\[Publication Type\], systematic review\[Text Word\], pooled analysis\[Text Word\].

Selection criteria for publications {#Sec4}
-----------------------------------

A first screening was done based on the title and abstract. Articles were considered for inclusion if they were MAs or pooled analyses describing the association between modifiable risk factors and development of bladder cancer, written in English. Inclusion was limited to articles published from 1995, as during the 1990s systematic reviews and meta-analyses started to replace narrative reviews, and methods and terminology were well established by that time \[[@CR16]\]. When the references could not be rejected with certainty, the full texts were obtained and a second screening was done. One article may report multiple MAs on different exposures.

The exposure of interest was any modifiable risk factor. 'Modifiable' was defined as a risk factor that is in any way reasonably modifiable, meaning that genetic and medical conditions were excluded as these are generally not modifiable. The outcome of interest was defined as incidence of bladder cancer as a binary outcome. Studies that included estimates based on prevalence or mortality were used as a proxy for incidence when estimates on incidence only were not available. Studies presenting results on genitourinary cancers without giving estimates for bladder cancer alone and studies reporting on urothelial cancer alone were excluded. Additionally, pooled risk estimates had to be presented with the accompanying 95 % confidence interval, accepted as odds ratio (OR), risk ratio (RR), hazard ratio (HR), standardised incidence ratio (SIR), or effect size (ES) if the latter consisted of a combination of the previously mentioned ratios. For the purpose of this paper, these estimates are all referred to as relative risks (RR).

Data extraction {#Sec5}
---------------

Data was extracted by AA and all entries were double-checked completely for errors by KS. Any disagreement was discussed between the review authors until consensus was reached. When needed, authors of publications were contacted for additional information.

For each article, the following data was extracted when available: first author, year of publication, journal, risk factor(s) studied, number of events, types of studies included, number of studies included, type of risk estimate (OR, RR, SIR), outcome variable (incidence, prevalence, mortality, or combination), and per MA (statistical procedure): the exposures that were compared, the risk estimate and the 95 % confidence interval, a measure of heterogeneity, the number of primary studies included, and a measure of publication bias.

Selection criteria for estimates {#Sec6}
--------------------------------

The estimates to be included had to be based on a minimum of two primary studies. They were selected based on the following list of decisions, and in this order: (1) bladder cancer only over urothelial cancers, (2) overall estimates over sub-group estimates, (3) more adjusted estimates over less adjusted estimates, (4) smoking adjusted over other adjustments, (5) incidence over prevalence or mortality, (6) random effects model over fixed effects model, and (7) pooling of cohort studies over pooling of case--control or cross-sectional studies.

Synthesis of results {#Sec7}
--------------------

If only one article was available on a specific risk factor, these estimates were included directly. If multiple articles were available, we selected the most comprehensive MA. This could occur in one of two ways. (1) The preferred method was to combine two MAs in a MMA to obtain an overall estimate based on the largest number of studies. However, we considered this only appropriate if the level of overlap between the primary studies included in each publication was no more than 50 %, measured as the percentage of studies of the smaller publication that overlapped with those of the larger publication. In addition, the exposure categories had to be comparable enough to be combined. (2) If, by following this rule, it was not possible to combine publications, the most comprehensive publication was included, based on the largest number of included primary studies. Basing this on the largest number of studies, rather than the largest sample size, was done because it was often not possible to determine the publication with the largest sample size due to insufficient data in the publication.

MMA was performed using a random-effects model. Heterogeneity was assessed between the included MAs using the I^2^ statistic \[[@CR17]\]. All statistical analyses were carried out in STATA V13.0 software and *p* values of 0.05 or below, or a confidence level of 95 %, were considered statistically significant.

In order to provide a measure of public health impact, a probability of causation \[[@CR18]\] (POC) was calculated for those risk estimates that were found to be significantly associated with the risk of bladder cancer. In addition, a combined POC \[[@CR18]\] was calculated for the lifestyle factors that one can be exposed to at one time. Careful attention was paid to avoid overlapping exposures, such as vitamin C intake, and fruit and vegetable consumption. In that case the most all-inclusive factor was included. No such combined estimate was calculated for all occupational factors combined, as one will unlikely be exposed to multiple occupations at one time.

POC can be interpreted as the percentage of exposed cases that are attributable to the exposure (e.g. the number of cases among smokers that are attributable to smoking). In case of a protective factor this should be read as the proportion of non-exposed cases that are attributable to the fact that they are non-exposed (e.g. the number of cases among people with low fruit and vegetable intake that are attributable to the low fruit and vegetable intake).

Role of the funding source {#Sec8}
--------------------------

The funding body was not involved in the study design; in the collection, analysis, or interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.

Results {#Sec9}
=======

Figure [1](#Fig1){ref-type="fig"} shows the literature search and selection process. A total of 1,496 articles were identified, from which 126 articles were selected based on the title and abstract for further evaluation. Of these, 32 articles were excluded (Appendix [1](#Sec51){ref-type="sec"}) for the following reasons: not being a MA, bladder cancer estimates were not reported separately from other urinary cancers, no risk estimate reported, or only mortality estimates were reported. Furthermore, 12 articles were excluded because all included primary studies were also part of a larger MA or because an update was available. This resulted in a total of 82 eligible articles (Appendix [2](#Sec52){ref-type="sec"}). Of these 82 articles, 21 articles were selected as the most comprehensive MA for a single risk factor, and five articles were combined in two MMAs, together reporting results for 36 risk factors. The statistically significant results from all most comprehensive MAs, totalling 19 lifestyle factors and 48 occupational factors, are summarised in Table [1](#Tab1){ref-type="table"} and illustrated in Figs. [2](#Fig2){ref-type="fig"} and [3](#Fig3){ref-type="fig"}, for the increased and decreased risks respectively.Fig. 1Flow diagram of literature search and selection processTable 1Modifiable risk factors with statistically significant association with bladder cancerRisk factorTotal MAsTotal primary studiesTotal BC cases in specific MAOutcome typeComparisonRelative risk (95 % CI)Confidence intervalPOC (%)Combined POC (%)*Lifestyle factors*Fruit and vegetable consumption \[[@CR19]\]110NSHigh versus low intake0.810.67--0.9919^\$^Fruit consumption \[[@CR19]\]1219867NSHigh versus low intake0.770.69--0.8723Citrus fruit \[[@CR20]\]1147372IncidenceHigh versus low intake0.850.76--0.9415Vegetable consumption \[[@CR19], [@CR21]\]2 (MMA)31 unique; 3 duplicate8808 unique; 765 duplicateNSHigh versus low intake0.830.75--0.9217Cruciferous vegetable \[[@CR19]\]1116496NSHigh versus low intake0.840.77--0.9116Processed meat \[[@CR33]\]1117562NSHigh versus low intake1.221.04--1.4318^\$^Vitamin A \[[@CR36]\]1114990NSHigh versus low intake (dietary and supplements) and blood levels0.820.65--0.9518Vitamin A supplement \[[@CR36]\]151403IncidenceSupplementation versus placebo or no supplementation0.640.47--0.8236Vitamin D \[[@CR39]\]152238Incidence/mortalityHigh versus low serum level0.750.65--0.8725Vitamin E \[[@CR38]\]1155224IncidenceHigh versus low intake0.820.74--0.9018Folate \[[@CR41]\]1136280IncidenceHigh versus low intake0.840.72--0.9616Selenium \[[@CR42]\]171014IncidenceHigh versus low serum or toenail level0.610.42--0.8739Antioxidant supplement \[[@CR44]\]14NRIncidenceSupplementation versus placebo or no supplementation1.521.06--2.1734Obesity \[[@CR46]\]112NSObese versus normal body weight1.101.03--1.189Cigarette smoking \[[@CR10]\]1139129IncidenceCurrent cigarette smokers versus never smokers3.142.53--3.7568^\$^1128659IncidenceFormer cigarette smokers versus never smokers1.831.52--2.1445Pipe smoking \[[@CR52]\]1634IncidencePipe only smokers versus never smokers1.901.2--3.147Cigar smoking \[[@CR52]\]1652IncidenceCigar only smokers versus never smokers2.301.6--3.557Physical activity \[[@CR56]\]17NRIncidenceHigh versus low0.860.77--0.9514^\$^Combined POC81.8*Occupational factors* \[[@CR61]\]Tobacco workers1387IncidenceVersus any other occupation1.721.37--2.1542Dye workers121344IncidenceVersus any other occupation1.581.32--1.9037Chimney sweeps14146IncidenceVersus any other occupation1.531.30--1.8135Nurses1131195IncidenceVersus any other occupation1.491.06--2.0833Rubber workers1451263IncidenceVersus any other occupation1.491.37--1.6133Waiters191146IncidenceVersus any other occupation1.431.34--1.5230Aluminium workers121977IncidenceVersus any other occupation1.411.29--1.5529Hairdressers1471445IncidenceVersus any other occupation1.321.24--1.4024Printers1421724IncidenceVersus any other occupation1.231.17--1.3019Seamen1101791IncidenceVersus any other occupation1.231.17--1.2919Oil and petroleum workers117637IncidenceVersus any other occupation1.201.06--1.3717Shoe and leather workers1391091IncidenceVersus any other occupation1.201.12--1.2917Plumbers181418IncidenceVersus any other occupation1.201.14--1.2717Sales agents19111923IncidenceVersus any other occupation1.171.15--1.2015Artistic workers1341678IncidenceVersus any other occupation1.161.10--1.2214Cooks and stewards1151117IncidenceVersus any other occupation1.151.08--1.2213Chemical process workers1793712IncidenceVersus any other occupation1.141.10--1.1912Metal workers1625461IncidenceVersus any other occupation1.141.11--1.1812Drivers15710396IncidenceVersus any other occupation1.141.11--1.1612Fishermen171525IncidenceVersus any other occupation1.131.08--1.1912Painters1433472IncidenceVersus any other occupation1.131.09--1.1712Assistant nurses12812IncidenceVersus any other occupation1.121.04--1.2011Domestic assistants1351776IncidenceVersus any other occupation1.121.07--1.1811Launderers and dry cleaners119767IncidenceVersus any other occupation1.121.04--1.2111Public safety workers--police1302382IncidenceVersus any other occupation1.111.07--1.1610Physicians110858IncidenceVersus any other occupation1.111.03--1.1910Clerical workers114821109IncidenceVersus any other occupation1.111.10--1.1310Electrical workers1455314IncidenceVersus any other occupation1.111.07--1.1410Military personnel1142091IncidenceVersus any other occupation1.111.05--1.1810Mechanics112767195IncidenceVersus any other occupation1.111.09--1.1310Smelting workers1242319IncidenceVersus any other occupation1.111.06--1.1610Transport workers1355243IncidenceVersus any other occupation1.101.06--1.139Glass makers, etc.1292219IncidenceVersus any other occupation1.101.05--1.159Textile workers1793822IncidenceVersus any other occupation1.101.06--1.149Waiters and bartenders1341179IncidenceVersus any other occupation1.101.01--1.199Building caretakers143246IncidenceVersus any other occupation1.091.06--1.138Health care workers1201072IncidenceVersus any other occupation1.091.06--1.128Food manufacturing workers1333559IncidenceVersus any other occupation1.081.04--1.127Postal workers141791IncidenceVersus any other occupation1.081.03--1.137Packers, loaders, and warehouse workers1253586IncidenceVersus any other occupation1.081.04--1.137Shop workers146068IncidenceVersus any other occupation1.071.05--1.107Technical workers, etc.13711579IncidenceVersus any other occupation1.041.02--1.064Economically inactive1223436IncidenceVersus any other occupation0.960.95--0.974Religious and legal workers, etc.161754IncidenceVersus any other occupation0.930.88--0.977Forestry workers15310865IncidenceVersus any other occupation0.880.86--0.9012Teachers1303884IncidenceVersus any other occupation0.850.82--0.8715Gardeners1103308IncidenceVersus any other occupation0.780.75--0.8122Farmers17316607IncidenceVersus any other occupation0.690.68--0.7131*BC* bladder cancer, *MA* meta-analysis, *MMA* meta-meta-analysis, *NS* not specified, *POC* probability of causation^\$^Risk factors and protective factors that have been included in the combined POC. The POC can be interpreted as the proportion of exposed cases that are attributable to the exposureFig. 2Forest plot of significantly increased risksFig. 3Forest plot of significantly decreased risks

Lifestyle factors {#Sec10}
-----------------

Four general topics emerged from the literature search with regard to lifestyle: dietary factors, consumption of tobacco, alcohol consumption, and physical activity.

### Dietary factors {#Sec11}

#### Fruit and vegetable {#Sec12}

The MA by Yao et al. \[[@CR19]\] was selected as the most comprehensive publication for overall fruit and vegetable intake and reported significant protective effect on bladder cancer (RR 0.81; 95 % CI 0.67--0.99; I^2^ = 58.4 %; n = 10).

#### Fruit only {#Sec13}

MA by Yao et al. \[[@CR19]\] was selected as most comprehensive for consumption of overall fruit and the MA by Liang et al. \[[@CR20]\] for intake of citrus fruit (e.g. oranges, lemons, limes, and grapefruits;). Overall fruit was associated with a reduced risk of bladder cancer (RR 0.77; 95 % CI 0.69--0.87; I^2^ = 54.9 %; n = 27) as were citrus fruit (highest vs. lowest intake: RR 0.85; 95 % CI 0.76--0.94; I^2^ = 72.1 %; n = 14). Yao et al. \[[@CR19]\] reported significant publication bias for overall and citrus fruit intake.

#### Vegetables only {#Sec14}

By pooling results from Yao et al. \[[@CR19]\] and Steinmaus et al. \[[@CR21]\] in a MMA, the most comprehensive estimate could be obtained for overall vegetable consumption (n = 31 unique and n = 3 duplicate primary studies). The MA by Yao et al. \[[@CR19]\] was selected as the most comprehensive publication for cruciferous vegetables. Consumption of overall vegetables (RR 0.83; 95 % CI 0.75--0.92; I^2^ = 0.0 %; n = 21 + 8) and cruciferous vegetables specifically (RR 0.84; 95 % CI 0.77--0.91; n = 11), resulted in a reduced risk of bladder cancer.

### Total fluid {#Sec15}

Bai et al. \[[@CR22]\] was the most comprehensive estimate and found no statistically significant association between total fluid intake and bladder cancer (RR 1.12; 95 % CI 0.94--1.33; I^2^ = 82.8 %; n = 14).

### Tea {#Sec16}

The MA by Qin et al. \[[@CR23]\] was selected as most comprehensive and they found a significant protective effect for black tea consumption (RR 0.79; 95 % CI 0.59--0.99; I^2^ = 33.1 %; n = 7) but not for overall and green tea consumption.

### Coffee {#Sec17}

Six MAs \[[@CR24]--[@CR28]\] reported on the association between coffee consumption and bladder cancer risk, of which Villanueva et al. \[[@CR27]\], Yu et al. \[[@CR26]\], and Wu et al. \[[@CR29]\] could be combined into a single estimate to provide the most comprehensive estimate (n = 38 unique and n = 3 duplicate primary studies). No statistically significant association was observed, with substantial heterogeneity (RR 1.12; 95 % CI 0.80--1.44; I^2^ = 94.2 %; n = 18 + 9 + 6).

### Sweetened carbonated beverages {#Sec18}

Only one MA by Boyle et al. \[[@CR30]\] was identified, reporting on the association between sweetened carbonated beverage consumption and risk of bladder cancer. No statistically significant association was found (RR 1.13; 95 % CI 0.89--1.45; n = 5).

### Milk and dairy products {#Sec19}

As reported by Mao et al. \[[@CR31]\], which was selected as most comprehensive, overall milk, skim milk, and fermented milk were associated with a significantly reduced incidence of bladder cancer (milk: RR 0.84; 95 % CI 0.72--0.97; I^2^ = 70.1 %; n = 16; skim milk: RR 0.47; 95 % CI 0.18--0.79; I^2^ = 0; n = 2; fermented milk: RR 0.69; 95 % CI 0.47--0.91; I^2^ = 62.5; n = 5). In contrast, consumption of whole milk was associated with a significantly increased risk of bladder cancer (RR 2.23; 95 % CI 1.45--3.00; I^2^ = 0; n = 2).

### Fish {#Sec20}

The MA by Li et al. \[[@CR32]\] was the only MA that studied the association between fish consumption and bladder cancer and reported no statistically significant association (RR 0.86; 95 % CI 0.61--1.12).

### Meat {#Sec21}

The MA by Li et al. \[[@CR33]\] was selected as most comprehensive and they found an increased risk of bladder cancer associated with processed meat (RR 1.22; 95 % CI 1.04--1.43; n = 11) but not with red meat (RR 1.15; 95 % CI 0.97--1.36; n = 14).

### Alcohol {#Sec22}

The MA by Pelucchi et al. \[[@CR34]\] was considered most comprehensive and they found no statistically significant association for heavy drinkers (≥ 3 drinks (≥ 37.5 g)/day; RR 0.97; 95 % CI 0.72--1.31; n = 7) or moderate drinkers (\<3 drinks/day; RR 0.98; 95 % CI 0.89--1.07; n = 15).

### Egg {#Sec23}

The MA by Li et al. \[[@CR35]\] was the only MA identified in which no significant association was detected for overall egg consumption (RR 1.11; 95 % CI 0.73--1.69; n = 6). However, when looking at cooking methods, an increased risk of bladder cancer was found for fried egg (RR 2.04; 95 % CI 1.41--2.95; n = 2) but not for boiled egg (RR 1.25; 95 % CI 0.82--1.91; n = 2).

### Vitamin A: body levels, intake, and supplementation {#Sec24}

The MA by Tang et al. \[[@CR36]\] was selected as most comprehensive MA for both overall intake and body levels of vitamin A, and vitamin A supplementation. They found a significantly lower risk of bladder cancer among individuals with higher dietary intake or higher blood levels of vitamin A (RR 0.82; 95 % CI 0.65--0.95; I^2^ = 46.3 %; n = 11). When looking only at intake of vitamin A, the association was significantly protective for vitamin A supplementation, consisting of beta-carotene, and/or retinol supplementation (highest vs. lowest: RR 0.64; 95 % CI 0.47--0.82; I^2^ = 0 %) but not for dietary intake (highest vs. lowest: RR 0.90; 95 % CI 0.80--1.01; I^2^ = 0 %).

Jeon et al. \[[@CR37]\] investigated the effect of only beta-carotene supplementation (so not retinol), compared to no supplementation, and found an increased risk of bladder cancer (RR 1.52; 95 % CI 1.03--2.24; I^2^ = 0.0 %; n = 2).

### Vitamin C {#Sec25}

The MA by Wang et al. \[[@CR38]\] was the only MA studying the association between vitamin C intake and bladder cancer. Combining vitamin C intake from diet and supplementation, they found a marginally significantly decreased risk of bladder cancer (RR 0.90; 95 % CI 0.79--1.00; I^2^ = 43.7 %; n = 20).

### Vitamin D {#Sec26}

The MA by Liao et al. \[[@CR39]\] investigated only the role of vitamin D serum level. They found that the risk of bladder cancer was decreased among individuals with the highest levels of serum vitamin D (RR 0.75; 95 % CI 0.65--0.87; n = 5). The MA by Chen et al. \[[@CR40]\] reported on the role of vitamin D intake from diet and supplements. Combining vitamin D intake from diet and supplementation, they found no significantly altered risk of bladder cancer (RR 0.92; 95 % CI 0.66--1.28; n = 3).

### Vitamin E {#Sec27}

The MA by Wang et al. \[[@CR38]\] was selected as the most comprehensive MA and reported significantly reduced risk of bladder cancer for vitamin E intake (RR 0.82; 95 % CI 0.74--0.90; I^2^ = 0 %; n = 15).

### Folate {#Sec28}

The association between folate intake and risk of bladder cancer was studied only in a MA by He et al. \[[@CR41]\]. They found a significantly reduced risk of bladder cancer (RR 0.84; 95 % CI 0.72--0.96; I^2^ = 28.9 %; n = 13). The association remained significantly reduced when pooling studies on dietary folate only (RR 0.82; 95 % CI 0.65--0.99; I^2^ = 57.9 %; n = 9), but not on supplemental folate only (RR 0.91; 95 % CI 0.58--1.25; I^2^ = 62.6 %; n = 3).

### Selenium: body levels and supplementation {#Sec29}

Two MAs \[[@CR42], [@CR43]\] were identified studying the association between selenium levels in the body, measured in serum or toenail, and bladder cancer. Amaral et al. \[[@CR42]\] was selected as the most comprehensive MA. They found that the risk of bladder cancer was significantly lower among individuals with the highest selenium levels in the body (RR 0.61; 95 % CI 0.42--0.87; n = 7).

Selenium supplementation was studied in one MA by Vinceti et al. \[[@CR43]\]. They meta-analysed two RCTs and found no statistically significant association (RR 1.14; 95 % CI 0.81--1.61; n = 2).

### Antioxidant supplementation {#Sec30}

One MA by Myung et al. \[[@CR44]\] reported on multiple types of antioxidant supplementation together, studied in RCTs. They found that antioxidant supplementation significantly increased the risk of bladder cancer (RR 1.52; 95 % CI 1.06--2.17; I^2^ = 0.0 %; n = 4).

### Dietary acrylamide {#Sec31}

The association between dietary acrylamide intake and bladder cancer was studied in one MA, authored by Pelucchi et al. \[[@CR45]\] They reported no statistically significant association (RR 0.93; 95 % CI 0.78--1.11; n = 3).

### Obesity {#Sec32}

Two MAs \[[@CR46], [@CR47]\] reported on the association between body weight and bladder cancer. The MA by Sun et al. \[[@CR46]\] was selected as most comprehensive. They found an increased risk of bladder cancer among obese individuals (BMI ≥ 30; RR 1.10; 95 % CI 1.03--1.18; I^2^ = 8.8 %; n = 12) but not among pre-obese individuals (BMI 25.00--29.99; RR 1.07; 95 % CI 0.99--1.16; I^2^ = 46.1 %; n = 13).

### Consumption of tobacco {#Sec33}

#### Active smoking {#Sec34}

Eight MAs \[[@CR10], [@CR11], [@CR48]--[@CR53]\] were identified on the effect of active smoking of tobacco on the risk of bladder cancer. With regard to cigarette smoking, Cumberbatch et al. \[[@CR53]\] and Van Osch et al. \[[@CR10]\] both included almost the same number of primary studies: n = 90 versus n = 89 respectively. Although theoretically this meant that the paper by Cumberbatch et al. would be most comprehensive, after discussion between the authors, the paper by Van Osch et al. was selected as most comprehensive as they reported dose--response analyses on duration, intensity, and time since cessation of smoking. Because smoking was already known to be the most important modifiable risk factor of bladder cancer, the dose--response variables were considered valuable additional information. It must be noted that calculated risks do not differ much between both MAs (Appendix [2](#Sec52){ref-type="sec"}).

Van Osch et al. \[[@CR10]\] reported a significantly increased risk of more than 3 times in current smokers (RR 3.14; 95 % CI 2.53--3.75) and almost 2 times in former smokers (RR 1.83; 95 % CI 1.52--2.14). Their dose--response associations showed a positive trend with increasing intensity of smoking and number of pack years, reaching a plateau from about 15 cigarettes/day and 50 pack-years. Increasing duration since cessation of smoking resulted in a reducing risk, although former smokers remained at a 50 % increased risk even after more than 20 years of cessation.

Hemelt et al. \[[@CR11]\] also reported on the risk among smokers of any type of tobacco. They found an increased incidence of bladder cancer among current smokers (RR 3.35; 95 % CI 2.90--3.88; n = 11) as well as among ever-smokers (RR 2.25; 95 % CI 1.96--2.59; n = 15).

Two MAs \[[@CR52], [@CR53]\] additionally reported on the effect of pure cigar and pure pipe smoking. Pitard et al. \[[@CR52]\] was considered most comprehensive and they reported a significantly increased risk of bladder cancer among both pipe smokers (RR 1.9; 95 % CI 1.2--3.1; n = 6) and cigar smokers (RR 2.3; 95 % CI 1.6--3.5; n = 6).

#### Passive smoking {#Sec35}

Van Hemelrijck et al. \[[@CR54]\] reported on the association between passive smoking and bladder cancer. They found no statistically significant association in individuals exposed to passive smoking (RR 0.99; 95 % CI 0.86--1.14; I^2^ = 35.6 %; n = 8) compared to never-smoking individuals with no exposure to passive smoking.

#### Smokeless tobacco {#Sec36}

Use of smokeless tobacco, including chewing tobacco, oral snuff, and unspecified smokeless tobacco, was studied in two MAs \[[@CR53], [@CR55]\]. Lee et al. \[[@CR55]\] was considered most comprehensive. No statistically significant association was found with development of bladder cancer (RR 0.95; 95 % CI 0.71--1.29; n = 9).

### Physical activity {#Sec37}

Keimling et al. \[[@CR56]\] wrote the only MA on the association between physical activity and bladder cancer. They found a statistically significant protective effect on the bladder cancer risk among individuals with the highest levels of physical activity (RR 0.86; 95 % CI 0.77--0.95; n = 7).

### Personal hair dye use {#Sec38}

Turati et al. \[[@CR57]\] updated previous MAs \[[@CR58]--[@CR60]\] to investigate the association between personal use of hair dye and bladder cancer. They found no statistically significant increased risk among users of personal hair dye (smoking adjusted RR 0.94; 95 % CI 0.82--1.08; n = 12).

Occupational factors {#Sec39}
--------------------

Multiple MAs were identified on the association between occupational factors and bladder cancer. Most MAs reported on a single occupation or occupational group, or a single specific occupational exposure (Appendix [2](#Sec52){ref-type="sec"}). Moreover, four MAs \[[@CR61]--[@CR64]\] reported on a large number of occupational categories. Cumberbatch et al. \[[@CR61]\] and Reulen et al. \[[@CR62]\] authored two large MAs on different occupations based on 217 and 130 different studies respectively, whereas Kogevinas et al. \[[@CR63]\] and 't Mannetje et al. \[[@CR64]\] both did a pooled analysis of eleven case--control studies conducted in European countries reporting results for men and women, respectively. The paper by Cumberbatch et al. was considered the most comprehensive for all identified occupations based on the number of studies included. They found the following occupations to have a statistically significant increased risk of more than 20 %: tobacco workers, dye workers, chimney sweeps, nurses, rubber workers, waiters, aluminium workers, hairdressers, printers, seamen, oil and petroleum workers, shoe and leather workers, and plumbers. Protective effects were found for farmers, gardeners, teachers, forestry workers, religious and legal workers, and economically inactive workers. Statistically significant associations reported by Cumberbatch et al. are listed in Table [1](#Tab1){ref-type="table"}. All other associations are summarized in Appendix [3](#Sec53){ref-type="sec"} along with findings by Reulen et al. \[[@CR62]\], Kogevinas et al. \[[@CR63]\], and 't Mannetje et al. \[[@CR64]\].

Probability of causation {#Sec40}
------------------------

The estimates for probability of causation (POC), displayed in percentages, are presented in Table [1](#Tab1){ref-type="table"}. The percentages ranged from 9 to 68 % among the lifestyle factors, and between 4 and 42 % for the occupational exposures. The four highest POCs are found among the smoking estimates: 68 % of the bladder cancer incidence among cigarette smokers, 57 % among cigar smokers, 47 % among pipe smokers and 45 % among former cigarette smokers can be attributed to this habit.

A POC was calculated for four factors combined, which were considered sufficiently independent: total fruit and vegetable consumption, processed meat consumption, smoking, and physical activity. To avoid overlap, the only estimate included for smoking was for cigarette smoking as most smokers are (also) cigarette smokers (78.7 %) and only 4.5 % was found to be pure pipe and/or cigar smoker \[[@CR52]\]. The combined POC showed that up to 81.8 % of the bladder cancer cases, among those with non-optimal lifestyle behaviours, could be prevented through lifestyle modifications.

Discussion {#Sec41}
==========

In total, 12 lifestyle factors and 48 occupational factors emerged that significantly increased or decreased the risk of bladder cancer. Such numerous modifiable risk factors present an opportunity and great potential for prevention. Below, the significantly associated risk factors will be discussed.

Smoking {#Sec42}
-------

The most important risk factor proved to be smoking, particularly the risk was highest for current smokers of cigarettes (RR 3.14), \[[@CR10]\] but also for smokers of cigars only (RR 2.3) and pipes only (RR 1.9) \[[@CR52]\]. An interesting finding was that a plateau was reached at about 15 cigarettes/day, meaning that heavier smoking does not carry a much higher risk than less heavy smoking \[[@CR10]\]. Although the risk slowly decreased with longer cessation of cigarette smoking, the RR was still 50 % increased 20 years of cessation.

Characteristics of the tobacco smoked may influence this association. In previous studies, individuals smoking black tobacco had a higher risk compared to smokers of blond tobacco, due to the higher concentrations of carcinogens in black tobacco \[[@CR65]--[@CR71]\]. Also, inhalation of the tobacco smoke into the lungs and throat resulted in a higher risk compared to inhalation only into the mouth, \[[@CR49], [@CR65], [@CR71]--[@CR76]\] although not all evidence supports this \[[@CR77]--[@CR80]\].

Tobacco smoke contains numerous carcinogens that contribute to the initiation and promotion of tumour development. These chemicals are renally excreted, making it directly toxic to the human urinary bladder. During metabolisation of these compounds, DNA-adducts are formed, leading to permanent genetic mutations. If this occurs in an oncogene or tumour suppressor gene, it may result in uncontrolled growth and eventually cancer.

Genetic mutations, such as NAT2 slow acetylation and GSTM null genotypes, have previously been shown to be associated with increased susceptibility to cancer \[[@CR3]\]. The enzymes for which the genes code play a role in the detoxification pathways of i.a. aromatic amines and PAHs. These mutations do not intrinsically cause bladder cancer but do increase susceptibility when exposed to tobacco smoke or other sources of exposure \[[@CR81], [@CR82]\].

Dietary factors {#Sec43}
---------------

Because the metabolites of many food groups are excreted by the urinary tract, dietary factors have often been suggested and researched as risk factors of bladder cancer \[[@CR83]\]. Several different nutritional factors have been identified, showing both increased and decreased risks of bladder cancer.

### Fruit, vegetables, and antioxidants {#Sec44}

One key group of foods that was associated with a lower risk of bladder cancer were fruits and vegetables. Besides these groups as a whole, intake of both citrus fruit and cruciferous vegetables were researched. The effect is suggested to be due to the vitamins, minerals, and phytochemicals that fruit and vegetables contain, which have antioxidant properties \[[@CR84], [@CR85]\]. Antioxidants may protect against cancer through inhibition of oxidation of DNA, controlling of cell proliferation and apoptosis \[[@CR85]\], and facilitation of metabolisation of carcinogenic compounds into less toxic substances, although the association may be dose-dependent \[[@CR86]\].

It should be noted that significant publication bias was found in the MA on overall and citrus fruit consumption \[[@CR19]\]. Because small studies with negative results tend not to be published, the effect size found in the MAs on these risk factors may actually be attenuated.

The MAs included in our review that studied vitamins separately, came to supporting conclusions. For all but vitamin C, higher intakes were associated with a significantly reduced risk of bladder cancer, with effects on −39 % for selenium, −18 % for vitamin A and E, and −16 % for folate.

Vitamin A intake was found to be negatively associated with bladder cancer when data on dietary intake, supplementation, and blood levels were combined. However, when studied by intake source separately, the protective effect was only found for vitamin A supplementation but not for dietary intake \[[@CR36]\]. Furthermore results on supplementation were not consistent as Jeon et al. \[[@CR37]\], found a significantly increased risk of bladder cancer of 52 % among participants taking supplementation in experimental studies. These conflicting results may be the result of a dose-dependent relationship, showing intake to be protective at low doses and harmful at high doses. Another explanation may be the different study design, in which the reduced risk found in observational studies may actually be the effect of an overall healthier lifestyle, as those individuals who choose to use nutritional supplementation tend to have a healthier lifestyle overall \[[@CR87]\], Vitamin A plays an important role in cell proliferation and differentiation \[[@CR88]\], and carotenoids can directly affect carcinogenesis through their antioxidant properties, or indirectly after transformation of provitamin A carotenoids into vitamin A \[[@CR89], [@CR90]\].

Vitamin E consists of a group of lipid soluble molecules, including four tocopherols and four tocotrienols. Specifically γ-tocopherol, δ-tocopherol, and tocotrienols inhibit several inflammatory pathways, \[[@CR91]\] which is important because chronic inflammation or chronic infection influences development and progression of cancer, \[[@CR92]\] In addition, vitamin E is a potent lipid-soluble antioxidant, inhibiting lipid peroxidation and thereby protecting cell membranes from peroxidative damage \[[@CR93]\].

Although higher levels of selenium protected against bladder cancer, causation could not be confirmed through supplementation intervention \[[@CR42]\], The specific mechanism of action of selenium in carcinogenesis is not yet well understood. Several theories have been suggested, including selenoproteins serving as antioxidants and metabolites of selenium involved in redox cycling, modification of protein thiols, and methionine mimicry \[[@CR94]\].

However, despite these suggested protective properties of antioxidants, analysis of multiple types of antioxidant supplementation together, showed a 52 % increased risk of bladder cancer \[[@CR44]\]. An explanation for this discrepancy may be that it is not one antioxidant alone that has cancer-preventative properties, but rather the interaction between multiple antioxidants and other phytochemicals, such as it occurs with consumption of a diet rich in fruit and vegetables.

### Other nutrients and food groups {#Sec45}

Because consumption of processed meat but not red meat was associated with bladder cancer, the effect may result from different forms of mechanical, chemical, and enzymatic treatment that processed meat has been exposed to. One hypothesis suggests that nitrite, which is used as a colour and flavour preservative in processed meat, combines with secondary amines from proteins to form nitrosamines that are found to be carcinogenic to, amongst other organs, the bladder \[[@CR95]\]. Although red and processed meat are often studied in relation to disease development, particularly cancer, the exact mechanism of action is still unclear and is likely to be a combination of factors present in or associated with meat consumption \[[@CR96], [@CR97]\].

The protective effect of folate, a vitamin predominantly found in vegetables, is suggested to be through its role in DNA synthesis, repair, and methylation \[[@CR98]\]. In previous research, low levels of folate were associated with hypomethylation of DNA resulting in dysregulation of proto-oncogenes and tumour suppressor genes, and therefore an increased risk of cancer \[[@CR99]\]. However, the association is not as straightforward as may be expected. Research suggests that timing and dose of folate plays an important role in its effect on cancer development \[[@CR100]\]. Because folate plays a role in de-novo synthesis of nucleotides, it will support healthy tissue and prevent tumour development. However, once pre-neoplastic lesions have been established, it will also support these rapidly proliferating tissues resulting in rapid tumour progression.

In line with previous findings for colorectal cancer \[[@CR101]\] and breast cancer, \[[@CR102]\] higher serum vitamin D was found to be protective against bladder cancer. Calcitriol, the potent hormone produced in the body from vitamin D, plays a role in multiple stages of cancer development, through both genomic and non-genomic pathways \[[@CR103]\]. No association was found for dietary and supplemental intake of vitamin D, which may result from dietary intakes not adequately reflecting calcitriol available to the body as it is also endogenously formed in response to UV-light.

Previous reviews have also mentioned other dietary factors increasing the risk of bladder cancer, among which higher intake of soy, fat, barbecued meats, and artificial sweeteners \[[@CR84], [@CR104]\]. However, no MAs were identified on these factors so these factors have not been included in our overview.

Fluid intake and water contaminants {#Sec46}
-----------------------------------

Whereas increased intake of fluids dilutes urine and increases micturition, leading to a reduced exposure of the bladder to carcinogens, it may also increase exposure when the fluid itself contains carcinogens \[[@CR3]\]. For example, increased risk of bladder cancer was found with water chlorination \[[@CR105], [@CR106]\] and arsenic contamination \[[@CR107], [@CR108]\]. However, no significant association was found for either all fluid intake or water specifically \[[@CR22]\]. Together, this is in line with the suggested dual effect of increased fluid intake on bladder cancer risk.

Physical activity {#Sec47}
-----------------

Physical activity was found to have a small but significant protective effect against bladder cancer. The effect found was not modified by BMI or smoking, as the authors explain in their MA \[[@CR56]\]. Although the exact mechanism through which physical activity protects against cancer is not yet known, several mechanisms have been suggested acting on both tumour initiation and progression. These potential mechanisms include modification of carcinogen activity, and enhancement of antioxidant and DNA repair processes \[[@CR109]\].

Occupation and occupational exposure to chemicals {#Sec48}
-------------------------------------------------

Occupational factors are considered the second most important risk factor for bladder cancer after smoking \[[@CR3], [@CR110]\]. Over the years, many carcinogens have been identified by the IARC as definitely (group 1) or probably carcinogenic (group 2a). Occupational exposure to these carcinogens has been largely controlled and workers are now exposed to weaker carcinogens. The results of the MA by Cumberbatch et al. \[53\] show multiple occupations or occupational exposures that are significantly associated with the risk of bladder cancer.

Particularly workers exposed to aromatic amines, PAH, tobacco and tobacco smoke, combustion products, and heavy metals are at an increased risk. However, these findings will not be further discussed and repeated here as the MA by Cumberbatch et al. \[[@CR61]\] offers an interesting and elaborate discussion on the matter. They also attempted to study a change in occupational risk over time but were limited by heterogeneity and small sample sizes.

Interestingly, farmers, gardeners, teachers, and forestry workers were found to be at a significantly lower risk. Farmers have been studied numerous times with regard to disease risk and have been suggested to be at both an increased and decreased risk of bladder cancer. It is thought of as a risk factor due to the exposure to chemicals such as pesticides, viruses, and other exposures. Although an increased risk was found in association with exposure to some pesticides, the evidence is not conclusive \[[@CR111]\]. Both the European Food Safety Authority (EFSA) \[[@CR112]\] and the IARC \[[@CR113]\] did not find sufficient evidence to support carcinogenicity of pesticides. On the other hand, farmers, and possibly also gardeners and forestry workers, often have higher physical activity levels and fruit and vegetable consumption, as well as a lower prevalence of smoking \[[@CR111]\].

Finally, in addition to exposure to carcinogens on an occupational basis, an increased risk of bladder cancer in certain occupational groups may also be the result of fewer possibilities for micturition during working hours. This may apply to, for example, sales workers, professional drivers, or other occupations where bathroom visits are limited to break times.

Public health impact {#Sec49}
--------------------

The calculated POCs show that by adopting the right lifestyle, while considering harmful environmental and occupational exposures, a large proportion of the burden of bladder cancer could be prevented. Particularly for smoking the POC was high, highlighting that smoking cessation and prevention of smoking initiation should remain high on the agenda. In addition, a diet rich in fruit and vegetables, particularly citrus fruit and cruciferous vegetables, and low in processed meat should be stimulated. Particularly working conditions involving exposure to aromatic amines, PAHs, tobacco and tobacco smoke, combustion products, and heavy metals should be given priority to reduce exposure to these compounds.

Limitations {#Sec50}
-----------

The quality of a MA is strongly determined by the quality of the primary studies included. Not all studies corrected for smoking status, which is the most important risk factor for bladder cancer. The effects of this may be large, leading to an under- or overestimation of the true effect size. To minimise the effect of confounding in our study, only the most adjusted estimates from each MA were selected. Selection of the most comprehensive publication was based on the largest number of primary studies included, rather than the largest sample size. The latter would have been more desirable as the power of a study depends on it, but this data was often unavailable in the publications and number of studies included had to be used as a proxy. Results of MMA could be affected by duplicate inclusion of primary studies, leading to inflated precision and homogeneity \[[@CR114]\]. Therefore, we minimised duplicate inclusion and performed a MMA only if at least 50 % of the included primary studies were 'new' in subsequent MAs.

The main limitation with regard to the combined POC is assumption of independence of risk factors. It is well known that lifestyle behaviours tend to cluster, \[[@CR115]\] indicating that the factors are unlikely to be fully independent. Therefore, the combined POC is likely to be an overestimation and should be considered a maximum. However, the POCs of each of the individual factors are substantial, indicating that each plays an important part in the risk.

In this study, estimates of bladder cancer incidence were given priority over estimates of prevalence or mortality. Although the majority of included studies specified the outcome measure that was included or provided stratified results, not all did (Table [1](#Tab1){ref-type="table"}). Because mortality and prevalence figures are greatly influenced by treatment success, this may have influence the estimates obtained.

Heterogeneity may always be an issue in MAs. Several of the studies included in the current review show moderate to high levels of heterogeneity. Whereas some identified study design, gender, or geographical region as possible source of heterogeneity \[[@CR19], [@CR22], [@CR31]\], others could not find an explanation \[[@CR20]\].

It should be noted that different classification criteria may be applied in studies to determine cases, including the TNM classification and stage grouping. Because any effect would be unlikely and small, this potential difference was not taken into consideration when selecting estimates.

This publication is a review of MAs. Additional risk factors for which no MA is available may prove to be of importance, but have not been included in this review. This study will help to identify gaps in knowledge with regard to MAs available.

It was our responsibility to give an objective and complete overview of the literature available. By using a protocol, including only MAs and by dealing appropriately with unexpected issues, we believe to have provided an overview of the risk factors associated with bladder cancer with high levels of objectivity and reliability.

In conclusion, the burden of bladder cancer could be significantly reduced through modification of lifestyle, environment, and occupational exposures. In fact, having numerous modifiable risk factors, among which multiple with a substantial RR, makes bladder cancer one of the most preventable diseases. Although substantial risks were found for, for example, smoking, some identified risk factors 'only' led to an increase or decrease of 10--15 %. This could be considered a minor effect, but reducing prevalence of a number of smaller risk factors together, could still result in significant overall risk reductions in the general population. Theoretically the included risk factors are, at least partially, modifiable. However, actually changing them is not always easily achieved, neither for one individual, let alone on a population level. Therefore, it is important that preventative and protective strategies pay attention to behaviour change in order to capture the greatest potential of risk reduction. When change is achieved, impact will not remain restricted to an improvement in the incidence of bladder cancer, as most of the included risk factors also play a role the risk of multiple other chronic diseases such as cancer or cardiovascular diseases, \[[@CR116]--[@CR118]\] and deaths \[[@CR119]\]. Since relapse of bladder cancer is common, future research may also elucidate whether the same risk factors play a role in prevention of bladder cancer relapse as they do in incidence.

Appendix 1 {#Sec51}
==========

See Table [2](#Tab2){ref-type="table"}.Table 2List of meta-analyses identified for modifiable risk factors of bladder cancerRisk factorIdentified meta-analysesIncludedIncluded for?Reason exclusion*Diet*Fruit and vegetablesRiboli and Norat \[[@CR120]\]NoAll primary studies are included in Yao et al. \[[@CR19]\]Liu et al. \[[@CR121]\]No\>50 % overlapVieira et al. \[[@CR122]\]No\>50 % overlapLiu et al. \[[@CR123]\]No\>50 % overlapXu et al. \[[@CR124]\]No\>50 % overlapSteinmaus et al. \[[@CR21]\]YesVegetables (MMA)Yao et al. \[[@CR19]\]YesFruit and vegetables\
Fruit\
Vegetables (MMA)\
Cruciferous vegetablesLiang et al. \[[@CR20]\]YesCitrus fruitTeaZeegers et al. \[[@CR125]\]NoInclude other urinary tract cancerZhang et al. \[[@CR126]\]No\>50 % overlapWu et al. \[[@CR127]\]No\>50 % overlapWang et al. \[[@CR128]\]No\>50 % overlapBoehm et al. \[[@CR129]\]NoNot MAQin et al. \[[@CR130]\]YesTeaCoffeeArab \[[@CR131]\]NoNot MAPelucchi et al. \[[@CR132]\]NoNot MAHuang et al. \[[@CR24]\]No\>50 % overlapSala et al. \[[@CR28]\]No\>50 % overlapZhou et al. \[[@CR25]\]No\>50 % overlapVillanueva et al. \[[@CR27]\]YesCoffee (MMA)Yu et al. \[[@CR26]\]YesCoffee (MMA)Wu et al. \[[@CR29]\]YesCoffee (MMA)Beverage consumptionZeegers et al. \[[@CR6]\]NoNot MABoyle et al. \[[@CR30]\]YesSweetened carbonated beveragesMilkZhang et al. \[[@CR133]\]NoNot MALampe \[[@CR134]\]NoNot MAMao et al. \[[@CR31]\]No\>50 % overlapLi et al. \[[@CR135]\]YesMilkFishLi et al. \[[@CR32]\]YesFishMeatWang and Jiang \[[@CR136]\]NoInclude urothelial cancerSteinmaus et al. \[[@CR21]\]NoLi et al. \[[@CR33]\]YesMeatAlcoholMao et al. \[[@CR137]\]NoInclude urothelial cancerde Menezes et al. [@CR138]\]NoNot MABagnardi et al. \[[@CR139]\]No\>50 % overlapZeegers et al. \[[@CR140]\]No\>50 % overlapPelucchi et al. \[[@CR34]\]YesAlcoholEggFang et al. \[[@CR141]\]NoInclude urothelial cancerLi et al. \[[@CR35]\]YesEggDietary acrylamidePelucchi et al. \[34\]YesDietary acrylamideVitamin ATang et al. \[[@CR36]\]YesVitamin ASteinmaus et al. \[[@CR21]\]NoVitamin DLiao et al. \[[@CR39]\]YesSerum levelChen et al. \[40\]YesDiet and supplementVitamin C & EWang et al. \[[@CR38]\]YesVitamin C\
Vitamin EChen et al. \[40\]\>50 % overlapFolate intakeHe and Shui \[[@CR41]\]YesFolateBeta carotene supplement, Antioxidant supplementMusa-Veloso et al. \[[@CR142]\]NoNo MA for bladder cancerCoulter et al. \[[@CR143]\]NoNo MA for bladder cancerJeon et al. \[[@CR37]\]YesBeta-carotene supplementsMyung et al. \[44\]YesAntioxidant supplementSeleniumAmaral et al. \[[@CR42]\]YesSelenium levels in the bodyVinceti et al. \[[@CR43]\]YesSelenium supplementationOmega-3 fatty acidsMacLean et al. \[[@CR144]\]NoNo MA for bladder cancerZinc, CopperMao et al. \[[@CR145]\]NoNo risk estimates reportedOlive oilPsaltopoulou et al. \[[@CR146]\]NoNo MA for bladder cancerFluid intakeLotan et al. \[[@CR147]\]NoNo MAStelmach and Clasen \[[@CR148]\]NoNo MAVillanueva et al. \[27\]NoIncluded in Bai et al. \[22\]Isa (submitted)No\>50 % overlapBai et al. \[22\]YesTotal fluid intakeObesityQin et al. \[47\]No\>50 % overlapSun et al. \[46\]YesObesity*Behaviours*SmokingZeegers et al. \[[@CR149]\]NoInclude other urinary tract cancerCrivelli et al. \[[@CR150]\]NoEffect of smoking on prognosis of bladder cancer patientsSasco et al. \[[@CR151]\]NoNo MAZeegers et al. \[[@CR6]\]NoNo MAVineis et al. \[[@CR152]\]NoNo MAShiels et al. \[[@CR153]\]NoNot primary prevention of BC't Mannetje et al. \[[@CR154]\]NoDiscussed whether adjusting for smoking affects association between BC and occupationFreedman et al. \[[@CR49]\]No\>50 % overlapBrennan et al. \[[@CR50]\]No\>50 % overlapBrennan et al. (Women) \[[@CR51]\]No\>50 % overlapHemelt et al. \[[@CR11]\]No\>50 % overlapPuente et al. \[[@CR48]\]No\>50 % overlapCumberbatch et al. \[[@CR53]\]No\>50 % overlapVan Osch et al. \[[@CR10]\]YesCigarette smokingCigar and pipePitard et al. \[[@CR52]\]YesCigar and pipePassive smokingVan Hemelrijck et al. \[[@CR54]\]YesPassive smokingSmokeless tobaccoLee et al. \[[@CR55]\]YesSmokeless tobaccoWaterpipe tobacco smokingAkl et al. \[[@CR155]\]NoWaterpipe tobacco smokingNo MA, reporting one CC studyPhysical activityKeimling et al. \[[@CR56]\]YesPhysical activity*Environmental*Personal hair dyes useKelsh et al. \[[@CR58]\]NoAll primary studies were included by Turati et al. \[[@CR57]\]Takkouche et al. \[[@CR60]\]NoAll primary studies were included by Turati et al. \[[@CR57]\]Huncharek et al. \[[@CR59]\]NoAll primary studies were included by Turati et al. \[[@CR57]\]Rollison et al. \[[@CR156]\]NoNo MATurati et al. \[[@CR57]\]YesPersonal hair dyes use*Occupational*Various occupationsCumberbatch et al. \[[@CR61]\]YesVarious occupationsVarious occupationsReulen et al. \[[@CR62]\]NoNot the most comprehensiveVarious occupationsKogevinas et al. \[[@CR63]\]NoNot the most comprehensiveVarious occupations\`t Mannetje et al. \[[@CR64]\]NoNot the most comprehensivePaintersBosetti et al. \[[@CR157]\]NoAll primary studies are included by Bachand (2010)Kogevinas et al. \[[@CR63]\]NoAll primary studies are included by Bosetti et al. \[[@CR157]\]Guha et al. \[[@CR158]\]No\>50 % overlapBachand et al. \[[@CR159]\]NoNot the most comprehensiveHairdresserKogevinas et al. \[[@CR63]\]NoAll primary studies included by Takkouche et al. \[[@CR160]\]\`t Mannetje et al. \[[@CR64]\]NoAll primary studies included by Takkouche et al. \[[@CR160]\]Takkouche et al. \[[@CR160]\]No\>50 % overlapHarling et al. \[[@CR161]\]NoNot the most comprehensiveSales workersKogevinas et al. \[[@CR63]\]Noincluded in't Mannetje et al. \[160\]Mannetje et al. \[[@CR162]\]No\>50 % overlapMotor vehicle drivingKogevinas et al. \[[@CR63]\]NoIncluded in Manju, 2009Boffetta and Silverman \[[@CR163]\]No\>50 % overlapManju et al. \[[@CR164]\]NoNot the most comprehensiveFarmersAcquavella et al. \[[@CR165]\]NoNot the most comprehensiveFoundry workersGaertner RR, 2002 \[[@CR166]\]NoNot the most comprehensiveTextile workersMastrangelo et al. \[[@CR167]\]NoNot the most comprehensiveFlight attendantsTokumaru et al. \[[@CR168]\]No\>50 % overlapBuja et al. \[[@CR169]\]NoPetroleum industryWong et al. \[[@CR170]\]NoMortality estimate onlyBaena et al. \[[@CR171]\]NoNot the most comprehensiveChemical workersGreenberg et al. \[[@CR172]\]NoNot the most comprehensiveDry cleaningVlaanderen et al. \[[@CR173]\]NoNot the most comprehensiveInorganic lead compoundsFu et al. \[[@CR174]\]NoNot the most comprehensiveAcrylonitrile workersCole et al. \[[@CR175]\]NoIncluded genitourinary cancersCollins and Acquavella \[[@CR176]\]NoNot the most comprehensivePolycyclic aromatic hydrocarbonsBosetti et al. \[[@CR177]\]NoUpdated in Rota et al. \[179\]Boffetta et al. \[[@CR178]\]NoNo MARota et al. \[[@CR179]\]NoNot the most comprehensiveMetalworking fluidsCalvert et al. \[[@CR180]\]NoNo MAPerchloroethylene (Dry cleaning)Mundt et al. \[[@CR181]\]NoNo MAAsbestos-exposed workersGoodman et al. \[[@CR182]\]NoMortality estimate only*CC* case--control, *MA* meta-analysis, *OR* odds ratio

Appendix 2 {#Sec52}
==========

See Table [3](#Tab3){ref-type="table"}.Table 3Characteristics of meta-analyses investigating association between bladder cancer risk and various factorsReferencesRisk factor (s)Primary studies included on bladder cancer in publicationComparisonSelected as best estimateRisk estimatesNumber of primary studies includedAdjustment levelHeterogeneityPublication bias (Egger test)*Dietary factors*Yao et al. \[[@CR19]\]Fruit, vegetables20 CC\
11 COHFruit and vegetables; high versus lowYesRR 0.81; 95 % CI 0.67--0.9910SmokingI^2^ = 58.4 %Fruit; high versus lowYesRR 0.77; 95 % CI 0.69--0.8727SmokingI^2^ = 54.9 %Egger *p* = 0.003Vegetables; high versus lowYes (MMA)RR 0.81; 95 % CI 0.70--0.9321SmokingI^2^ = 66.0 %Egger *p* = 0.389Citrus Fruits; high versus lowNoRR 0.79; 95 % CI 0.68--0.9111I^2^ = 53.2 %Egger *p* = 0.034Cruciferous vegetables; high versus lowYesRR 0.84; 95 % CI 0.77--0.9111I^2^ = 30.7 %Egger *p* = 0.443Steinmaus et al. \[[@CR21]\]Fruit (low intake)38 CC and COHFruits; low versus highNoRR 1.47; 95 % CI 1.25--1.748SmokingX^2^ *p* = 0.99^\$^Vegetables (low intake)Vegetables; low versus highYes (MMA)RR 1.15; 95 % CI 0.98--1.358SmokingX^2^ *p* = 0.82^\$^MeatHigh versus lowNoRR 0.96; 95 % CI 0.73--1.274SmokingX^2^ *p* = 0.97^\$^Vitamin ARetinol; low versus high intakeNoRR 1.01; 95 % CI 0.90--1.148X^2^ *p* = 0.99^\$^CarotinoidsCarotenoids; low versus high intakeNoRR 1.10; 95 % CI 0.99--1.223X^2^ *p* = 0.99^\$^Vieira et al. \[[@CR122]\]Fruit, Vegetables15 COHFruit and vegetables; high versus lowNoRR 0.89; 95 % CI 0.75--1.058I^2^ = 33.8 %Fruit; high versus lowNoRRs = 0.91; 95 % CI 0.82--1.0011SmokingI^2^ = 11.0 %Egger *p* = 0.48Vegetables; high versus lowNoRRs = 0.92; 95 % CI 0.84--1.019SmokingI^2^ = 5.0 %Egger *p* = 0.02Citrus fruit; high versus lowNoRRs = 0.88; 95 % CI 0.77--1.016SmokingI^2^ = 0.0 %Egger *p* = 0.38Cruciferous vegetables; high versus lowNoRRs = 0.85; 95 % CI 0.69--1.066SmokingI^2^ = 62.6 %Egger *p* = 0.5Liu et al. \[[@CR123]\]Fruit, vegetables15 CC\
12 COHFruit and vegetables; high versus lowNoRR 0.83; 95 % CI 0.69--1.019I^2^ = 57.0 %Fruit; high versus lowNoRR 0.81; 95 % CI 0.73--0.8927I^2^ = 53.7 %Egger *p* = 0.052Vegetables; high versus lowNoRR 0.84; 95 % CI 0.72--0.9624I^2^ = 76.3 %Egger *p* = 0.74Xu et al. \[[@CR124]\]Fruit, vegetables14 COHFruit and vegetables; every 0.2 serving increment per dayNoRR 1.00; 95 % CI 0.99--1.008I^2^ = 38.5 %Fruit; every 0.2 serving increment per dayNoRRs = 1.00; 95 % CI 0.99--1.0014SmokingI^2^ = 45.8 %Egger *p* \< 0.01Vegetables; every 0.2 serving increment per dayNoRRs = 1.00; 95 % CI 0.99--1.0014SmokingI^2^ = 19.0 %Egger *p* = 0.93Citrus fruit; every 0.2 serving increment per dayNoRRs = 1.00; 95 % CI 1.00--1.007I^2^ = 0.0 %Cruciferous vegetables; every 0.2 serving increment per dayNoRRs = 0.97; 95 % CI 0.93--1.018I^2^ = 55.8 %Liang et al. \[[@CR20]\]Citrus fruits8 CC\
6 COHCitrus fruits; high versus lowYesRR 0.85; 95 % CI 0.76--0.9414I^2^ = 72.1 %Egger *p* = 0.0046 COHCitrus fruits; high versus lowNoRR 0.96; 95 % CI 0.87--1.076I^2^ = 19.8 %8 CCCitrus fruits; high versus lowNoRR 0.77; 95 % CI 0.64--0.928I^2^ = 68.7 %Liu et al. \[[@CR121]\]Cruciferous vegetables5 CC\
5 COHCruciferous vegetables; high versus lowNoRR 0.80; 95 % CI 0.69--0.9210I^2^ = 45.9 %Egger *p* = 0.515 COHCruciferous vegetables; high versus lowNoCohort: RR 0.86; 95 % CI 0.61--1.115I^2^ = 73 %5 CCCruciferous vegetables; high versus lowNoCC: RR 0.78; 95 % CI 0.67--0.895I^2^ = 0.0 %Bai et al. \[[@CR22]\]Total fluid intake17 CC\
4 COHHigh versus lowYesRRm = 1.12; 95 % CI 0.94--1.3314Most adjustedI^2^ = 82.8 %Egger *p* = 0.059Isa (submitted)Total fluid intake15 CC\
3 COH250 ml/day incrementNoRR 1.02; 95 % CI 1.00--1.0415Egger *p* = 0.614Zhang et al. \[[@CR126]\]Tea7 COHAll tea; high versus lowNoRR 0.92; 95 % CI 0.76--1.137I^2^ = 23.8 %All tea; one cup/day incrementNoRR 0.98; 95 % CI 0.93--1.027I^2^ = 44.1 %Green tea; one cup/day incrementNoRR 1.02; 95 % CI 0.95--1.113I^2^ = 63.9 %Black tea; one cup/day incrementNoRR 0.73; 95 % CI 0.33--1.601Wu et al. \[[@CR127]\]Tea12 CC\
3 COHAll tea; high versus lowNoRRm = 1.01; 95 % CI 0.80--1.297Most adjustedEgger *p* = 0.88Green tea; high versus lowNoRR 1.03; 95 % CI 0.82--1.315I^2^ = 0.0 %Egger *p* = 0.49Black tea; high versus lowNoRR 0.84; 95 % CI 0.7--1.016I^2^ = 0.0 %Egger *p* = 1.0Wang et al. \[[@CR128]\]Tea13 CC\
4 COHAll tea; high versus lowNoRRm = 1.12; 95 % CI 0.88--1.43; I^2^ = 64.6 %; n = 1717Most adjustedEgger *p* = 0.298Green tea; high versus lowNoRR 0.81; 95 % CI 0.68--0.984I^2^ = 0.0 %Egger *p* = 0.73Black tea; high versus lowNoRR 1.05; 95 % CI 0.83--1.325I^2^ = 49.4 %Egger *p* = 0.41Qin et al. \[[@CR130]\]Tea17 CC\
6 COHAll tea; high versus lowYesRR 0.94; 95 % CI 0.85--1.0423I^2^ = 28.3 %Egger *p* = 0.52Green tea; high versus lowNoRR 0.97; 95 % CI 0.73--1.21;5I^2^ = 0.0 %Egger *p* = 0.38Black tea; high versus lowNoRR 0.79; 95 % CI 0.59--0.997I^2^ = 33.1 %Egger *p* = 0.38Huang et al. \[[@CR24]\]Coffee5 COHHigh versus none/lowNoRR 1.08; 95 % CI 0.71--1.665I^2^ = 62.9 %Zhou et al. \[[@CR25]\]Coffee20 CC\
5 COHHigh (\>5--6 cups/day) versus noneNoCase--control: RRs = 1.45; 95 % CI 1.29--1.63\
This category was not calculated for cohort studies20I^2^ = 31.8 %No publication bias (no test estimate reported)Sala et al. \[[@CR28]\]CoffeePooled analysis of 10 CC6--9 cups versus noneNoRRm = 1.0; 95 % CI 0.6--1.4Most adjusted, analysis restricted to non-smokers≥10 cups versus noneNoRRm = 1.8; 95 % CI 1.0--3.3Most adjusted, analysis restricted to non-smokersVillanueva et al. \[[@CR27]\]CoffeePooled analysis of 6 CC\>5 cups/day versus ≤5 cups/day; overallYes (MMA)RRms = 1.25; 95 % CI 1.08--1.446Most adjusted, incl. smoking\>5 cups/day versus ≤5 cups/day; men onlyNoRRms = 1.23; 95 % CI 1.05--1.445Most adjusted, incl. smoking\>5 cups/day versus ≤5 cups/day; women onlyNoRRms = 1.31; 95 % CI 0.99--1.745Most adjusted, incl. smoking1 l/day incrementNoRRms = 1.24; 95 % CI 1.08--1.436Most adjusted, incl. smokingYu et al. \[[@CR26]\]Coffee9 COHDrinkers versus none/lowestYes (MMA)RR 0.83; 95 % CI 0.73--0.949I^2^ = 39.3 %Egger *p* = 0.793Wu et al. \[[@CR29]\]Coffee34 CC\
6 COHHigh versus lowYes (MMA)RRms = 1.28; 95 % CI 1.21--1.4618Most adjusted, incl. smokingI^2^ = 28.5Egger *p* = 0.051Boyle et al. \[[@CR30]\]Sweetened carbonated beverages5 studiesHigh versus lowYesRR 1.13; 95 % CI 0.89--1.455I^2^ = 0.0 %Egger *p* = 0.05Li et al. \[[@CR135]\]Milk\
Dairy products12 CC\
6 COHMilk; high versus lowYesRRm = 0.91; 95 % CI 0.72--1.157Most adjustedQ *p* = 0.020Egger *p* = 0.048Dairy products; high versus lowYesRRm = 1.01; 95 % CI 0.86--1.193Most adjustedQ *p* = 0.108Egger *p* = 0.73Mao et al. \[[@CR31]\]Milk and Dairy products8 HCC\
5 PCC\
6 COHAll milk; high versus lowNoRRms = 0.84; 95 % CI 0.72--0.9716Most adjusted, incl. smokingI^2^ = 70.1 %Egger *p* = 0.055Whole milk; high versus lowNoRR 2.23; 95 % CI 1.45--3.002I^2^ = 0Skim milk; high versus lowNoRR 0.47; 95 % CI 0.18--0.792I^2^ = 0Fermented milk; high versus lowNoRR 0.69; 95 % CI 0.47--0.915I^2^ = 62.5 %Li et al. \[[@CR32]\]Fish6 HCC\
3 PCC\
5 COHHigh versus lowYesRRs = 0.86; 95 % CI 0.61--1.12; I^2^ = 85.4 %; n = 14; Begg's *p* = 0.10114SmokingLi et al. \[[@CR33]\]Meat9 CC\
5 COHRed meat; high versus lowYesRR 1.15; 95 % CI 0.97--1.3614I^2^ = 73.5 %Egger *p* = 0.836 CC\
5 COHProcessed meat; high versus lowYesRR 1.22; 95 % CI 1.04--1.4311I^2^ = 64.9 %Egger *p* = 0.35Pelucchi et al. \[[@CR34]\]Alcohol14 CC\
2 NCC\
3 COHHeavy intake, ≥ 3 drinks (≥ 37.5 g)/day versus non-drinkersYesRR 0.97; 95 % CI 0.72--1.317SmokingX^2^ *p* \< 0.01Moderate intake, \<3 drinks/day versus non-drinkersNoRR 0.98; 95 % CI 0.89--1.0715SmokingX^2^ *p* = 0.05Bagnardi et al. \[[@CR139]\]Alcohol9 CC\
2 COHHighest category (100 g/day) versus non-drinkersNoRR 1.17; 95 % CI: 0.97--1.4111Het. *p* = N.S.Highest category (100 g/day) versus non-drinkersNoRRs = 1.09; 95 % CI: 0.89--1.33SmokingHet. *p* \< 0.05Zeegers et al. \[[@CR140]\]Alcohol6 studiesCurrent alcohol use versus non-useNoRR 1.3; 95 % CI 1.1--1.56Li et al. \[[@CR35]\]Egg9 CC\
4 COHAll eggs; high versus lowYesRRm = 1.11; 95 % CI 0.73--1.696Most adjustedI^2^ = 75.8 %Egger *p* = 0.55Fried eggs; high versus lowNoRR 2.04; 95 % CI 1.41--2.952I^2^ = 0.0 %Boiled eggs; high versus lowNoRR 1.25; 95 % CI 0.82--1.912I^2^ = 35.5 %Pelucchi et al. \[[@CR45]\]Dietary acrylamide1 CC\
1 COH\
1 C-COHHigh versus lowYesRR 0.93; 95 % CI 0.78--1.113X^2^ *p* = 0.9110 mg/day increase in intakeNoRR 1.00; 95 % CI 0.96--1.033X^2^ *p* = 0.97Tang et al. \[[@CR36]\]Vitamin A (total)14 CC\
11 COHSupplement, diet and blood levels; high versus lowYesRRms = 0.82; 95 % CI 0.65--0.9511Most adjusted, incl. smokingI^2^ = 46.3 %Egger *p* = 0.057Dietary intake; high versus lowNoRRms = 0.90; 95 % CI 0.80--1.01Most adjusted, incl. smokingI^2^ = 0 %Supplementation versus placebo or no supplementationYesRRms = 0.64; 95 % CI 0.47--0.82Most adjusted, incl. smokingI^2^ = 0 %Jeon et al. \[[@CR37]\]Beta-carotene supplements2 RCTSupplementation versus placebo or no supplementationNoRR 1.52; 95 % CI 1.03--2.242I^2^ = 0.0 %Liao et al. \[[@CR39]\]Vitamin D1 CC\
2 NCC\
2 COHSerum levels; high versus lowYesRRs = 0.75; 95 % CI 0.65--0.875SmokingI^2^ = 0.0 %Egger *p* = 0.57Chen et al. \[[@CR40]\]Vitamin D1 CC\
3 COHCirculating levels; high versus lowNoRR 0.75; 95 % CI 0.57--0.994I^2^ = 51.7 %Egger *p* = 0.873 studiesDiet and supplement; high versus lowNoRR 0.92; 95 % CI 0.66--1.283I^2^ = 32.3 %Egger *p* = 0.41Vitamin E4 CC\
5 COHDiet; high versus lowNoRRm = 0.69; 95 % CI 0.52--0.925I^2^ = 47.1 %Egger *p* = 0.013 CC\
3 COHDiet and supplement; high versus lowNoRRm = 0.76; 95 % CI 0.56--1.025I^2^ = 49.8 %Egger *p* = 0.351 CC\
6 COHSupplementation versus placebo or no supplementationNoRRm = 0.64; 95 % CI 0.48--0.85I^2^ = 0.6 %Egger *p* = 0.39Vitamin C7 CC\
7 COHDiet; High versus LowNoRRm = 0.69; 95 % CI 0.58--0.826I^2^ = 13.7 %Egger *p* = 0.285 CC\
3 COHDiet and supplement; high versus lowNoRRm = 0.80; 95 % CI 0.62--1.035I^2^ = 33.4 %Egger *p* = 0.036 CC\
3 COHSupplementation versus placebo or no supplementationNoRRm = 0.84; 95 % CI 0.55--1.294I^2^ = 74.4 %Egger *p* = 0.002Wang et al. \[[@CR38]\]Vitamin C11 CC\
9 COHIntake; high versus lowYesRRs = 0.90; 95 % CI 0.79--1.0020SmokingI^2^ = 43.7 %Egger *p* = 0.064Vitamin E7 CC\
8 COHIntake; high versus lowYesRRs = 0.82; 95 % CI 0.74--0.9015SmokingI^2^ = 0 %Egger *p* = 0.534He et al. \[[@CR41]\]Folate6 CC\
7 COHIntake; high versus lowYesRR 0.84; 95 % CI 0.72--0.9613I^2^ = 28.9 %Egger *p* = 0.06Myung et al. \[[@CR37]\]Antioxidant supplement4 RCTSupplementation versus placebo or no supplementationNoRR 1.52; 95 % CI 1.06--2.174I^2^ = 0.0 %Amaral et al. \[[@CR42]\]Selenium3 CC\
3 NCC\
1 C-COHSerum and toenail levels; high versus lowYesOR = 0.61; 95 % CI 0.42--0.877I^2^ = 60.8 %Egger *p* = 0.357Vinceti et al. \[[@CR43]\] (Cochrane SR)Selenium5 prospective studiesSerum, toenail or plasma levels; high versus lowNoOR = 0.67; 95 % CI 0.46--0.975I^2^ = 30 %2 RCTSupplementation versus PlaceboYesRR 1.14; 95 % CI 0.81--1.612I^2^ = 0.0 %Sun et al. \[[@CR46]\]Obesity15 COHObese versus normal weightYesRRs = 1.10; 95 % CI 1.03--1.1812SmokingI^2^ = 8.8 %Egger *p* = 0.712Pre-obese versus normal weightYesRRs = 1.07; 95 % CI 0.99--1.1613SmokingI^2^ = 46.1 %Egger *p* = 0.712Qin et al. \[[@CR47]\]Obesity11 COHObese versus normal weightNoRRs = 1.09; 95 % CI 1.01--1.179SmokingI^2^ = 35.9 %Egger *p* = 0.244*Behavioural factors*Hemelt et al. \[[@CR11]\]Smoking21 CC\
11 COH\
2 NCCAll tobacco; Ever smokers versus never smokersNoRR 2.25; 95 % CI 1.96--2.5915All tobacco; Ex smokers versus never smokersNoRR 1.90; 95 % CI 1.71--2.118All tobacco; Current smokers versus never smokersNoRR 3.35; 95 % CI 2.90--3.8811Cigarettes; Ever smokers versus never smokersNoRR 2.24; 95 % CI 1.81--2.789Cigarettes; Ex smokers versus never smokersNoRR 1.95; 95 % CI 1.55--2.474Cigarettes; Current smokers versus never smokersNoRR 3.13; 95 % CI 2.33--4.216Puente et al. \[[@CR48]\]SmokingPooled analysis of 14 CCCurrent smokers versus never smokers; MaleNoRR 3.89; 95 % CI 3.53--4.29Current smokers versus never smokers; FemaleNoRR 3.55; 95 % CI 3.06--4.10Ex-smokers versus never smokers; MaleNoRR 2.21; 95 % CI 2.01--2.43Ex-smokers versus never smokers; FemaleNoRR 2.21; 95 % CI 1.87--2.61Freedman et al. \[[@CR49]\]Smoking7 COHCurrent smokers versus never smokersNoRR 2.94; 95 % CI 2.45--3.547I^2^ = 0.0 %Egger *p* = 0.32Brennan et al. \[[@CR50]\]SmokingPooled analysis of 11 CC (men only)Ever-smokers versus never smokersNoRR 3.63; 95 % CI 3.13--4.20Current smokers versus never and ex-smokersNoRR 2.47; 95 % CI 2.23--2.74Brennan et al. \[[@CR51]\]SmokingPooled analysis of 11 CC (women only)Ever-smokers versus never smokersNoRR 3.1; 95 % CI 2.5--3.9Current smokers versus never and ex-smokersNoRR 2.9; 95 % CI 2.3--3.7Van Osch et al. submitted \[[@CR10]\]Active smoking18 COH\
71 CCActive smoking; Ex-smokers versus never smokersYesRR 1.83; 95 % CI 1.52--2.1412Age, sexEgger *p* = 0.150Active smoking; Current smokers versus never smokersYesRR 3.14; 95 % CI 2.53--3.7513Age, sexActive smoking; ≤20 versus \>20 years at first exposureNoRR 1.33; 95 % CI 0.92--1.744Cumberbatch et al. \[[@CR53]\]Active smokingEx-smokers versus never smokersNoRR 3.37; 95 % CI 3.01--3.7848Most adjusted estimates in MAI^2^ = 82.2 %Egger *p* = 0.13\
Begg *p* = 0.03Current smokers versus never smokersNoRR 1.98; 95 % CI 1.76--2.2249Most adjusted estimates in MAI^2^ = 78.6 %Pipe; Smokers versus never smokersNoRR 1.49; 95 % CI 1.18--1.884I^2^ = 39.4 %Cigar; Smokers versus never smokersNoRR 1.62; 95 % CI 1.18--2.224I^2^ = 0.0 %Smokeless tobaccoSnuff; users versus non-usersNoRR 0.89; 95 % CI 0.56--1.422I^2^ = 23.7 %Chewing tobacco; users versus non-usersNoRR 1.04; 95 % CI 0.75--1.452I^2^ = 0.0 %Pitard et al. \[[@CR52]\]Active smokingPooled analysis of 6 CC (men only)Pipe only; Smokers versus never smokersYesRR 1.9; 95 % CI 1.2--3.1Cigar only; Smokers versus never smokersYesRR 2.3; 95 % CI 1.6--3.5Cigarette only; Smokers versus never smokersNoRR 3.5; 95 % CI 2.9--4.2Van Hemelrijck et al. \[[@CR54]\]Passive smoking5 CC\
3 COHExposed versus not exposedYesRR 0.99; 95 % CI 0.86--1.148Non-smokers onlyI^2^ = 35.6 %Begg *p* = 0.32Lee et al. \[[@CR55]\]Smokeless tobacco12 CC\
1 COHSmokeless tobacco use versus never useYesRRs = 0.95; 95 % CI 0.71--1.299SmokingI^2^ = 59.6 %Keimling et al. \[[@CR56]\]Physical activity4 CC\
11 COHHigh versus lowYesRRm = 0.86; 95 % CI 0.77--0.957Most adjustedI^2^ = 0.0 %Turati et al. \[[@CR57]\]Personal hair dye15 CC\
2 COHPersonal use of any type of hair dyes versus no useYesRRs = 0.94; 95 % CI 0.82--1.0812SmokingI^2^ = 49.9 %Egger *p* = 0.54Occupational (Comparing the specific occupation versus any other occupation or the general population)Guha et al. \[[@CR158]\]Painters30 CC\
2 COH\
9 RLPaintersNoRR 1.25; 95 % CI 1.16--1.3441I^2^ = 23.5 %PaintersNoRRs = 1.28; 95 % CI 1.15--1.43SmokingI^2^ = 0.7 %PaintersNoRRms = 1.27; 95 % CI 0.99--1.63Most adjusted, incl. smokingI^2^ = 0.1 %Bachand et al. \[[@CR159]\]Painters33 CCPaintersNoRR 1.30; 95 % CI 1.17--1.4433Smoking; morbidity and mortality combined4 COHPaintersNoRR 1.23; 95 % CI 0.95--1.594Smoking; morbidity onlyHarling et al. \[[@CR161]\]Hairdressers28 CC\
14 RCOHHairdressersNoRR 1.35; 95 % CI 1.13--1.6123SmokingX^2^ *p* = 0.19Hairdressers; job held ≥ 10 yearsNoRR 1.70; 95 % CI 1.01--2.886X^2^ *p* = 0.46Takkouche et al. \[[@CR160]\]Hairdressers26 CC\
8 COHHairdressersNoRR 1.33; 95 % CI 1.07--1.6719SmokingQ *p* = 0.77HairdressersNoRR 1.35; 95 % CI 1.21--1.5026Incidence onlyQ *p* = 0.78't Mannetje et al. \[[@CR162]\]Sales workers10 CC\
2 RL\
3 mortality studiesSales workers; MenNoRR 1.04; 95 % CI 0.97--1.12Smoking, incidence onlyQ *p* = 0.3Egger *p* = 0.4Sales workers; WomenNoRR 1.22; 95 % CI 1.06--1.41Smoking, incidence onlyQ *p* = 0.44Egger *p* \< 0.01Manju L et al. \[[@CR164]\]Motor vehicle driving3 COHOverall (motor vehicle drivers and railroad workers)NoRR 1.08; 95 % CI 1.00--1.173Het. *p* = 0.8527 CCTruck driversNoRR 1.18; 95 % CI 1.09--1.2818Het. *p* = 0.2527 CCBus driversNoRR 1.23; 95 % CI 1.06--1.4411Het. *p* = 0.19Boffetta and Silverman \[[@CR163]\]Motor vehicle driving16 CC\
7 COH\
6 routinely collected data\
(men only)Truck driversNoRR 1.17; 95 % CI 1.06--1.2915Het. *p* = 0.3Egger *p* = 0.07Bus driversNoRR 1.33; 95 % CI 1.22--1.4510Het. *p* = 0.4Egger *p* = 0.001Acquavella et al. \[[@CR165]\]Farmers10 Follow-up studies\
8 CC\
11 PMR\
(men only)FarmersNoRR 0.79; 95 % CI 0.72--0.8629X^2^ *p* \< 1\*10^−5^10 Follow-up studiesFarmersNoRR 0.62; 95 % CI 0.59--0.6510X^2^ *p* = 0.088 CCFarmersNoRR 0.94; 95 % CI 0.86--1.048X^2^ *p* = 0.09Gaertner et al. \[[@CR166]\]Foundry workers22 CC\
9 COH\
14 surveillance studiesFoundry workersNoRR 1.11; 95 % CI 0.96--1.2916 (CC only)SmokingX^2^ *p* = 0.07 (15df)Foundry workersNoRR 1.14; 95 % CI 1.04--1.26;11Incidence onlyX^2^ *p* = 0.28 (10df)Mastrangelo et al. \[[@CR167]\]Textile workersUnknownSpinnersNoRR 1.19; 95 % CI 0.80--1.572X^2^ *p* \< 0.001^\$^WeaversNoRR 2.40; 95 % CI 1.62--3.182X^2^ *p* = 0.001^\$^DyersNoRR 1.39; 95 % CI 1.07--1.713X^2^ *p* = 0.505^\$^Tokumaru et al. \[[@CR168]\]Flight attendants3 COH (female only)Flight attendantsNoRR 2.03; 95 % CI 0.75--5.433Incidence onlyQ *p* = N.S.Buja et al. \[[@CR169]\]Flight attendants4 COH (female only)Flight attendantsNoRR 1.45; 95 % CI 0.33--3.164Incidence onlyTau = 0.39Baena et al. \[[@CR171]\]Petroleum industry8 CCPetroleum industry workersNoRR 1.5; 95 % CI 1.29--1.758Greenberg et al. \[[@CR172]\]Chemical workers19 COH for incidenceChemical workersNoRR 2.21; 95 % CI 1.18--4.1519Incidence onlyVlaanderen et al. \[[@CR173]\]Dry cleaning4 CC\
3 COHDry cleaning workersNoRR 1.47; 95 % CI 1.16--1.857I^2^ = 0 %Egger *p* \> 0.05Fu et al. \[[@CR174]\]Inorganic lead compounds5 studiesExposed to inorganic lead compounds versus non-exposedNoRR 1.41; 95 % CI 1.16--1.715Hom. *p* \> 0.30Collins et al. \[[@CR176]\]Acrylonitrile workers10 studiesAcrylonitrile workersNoRR 0.8; 95 % CI 0.3--2.23IncidenceHet. *p* = 0.49Rota et al. \[[@CR179]\]Polycyclic aromatic hydrocarbons (PAHs)13 COHAluminium production workersNoRR 1.28; 95 % CI 0.98--1.6810X^2^ *p* = 0.002Egger *p* = 0.22Asphalt workersNoRR 1.03; 95 % CI 0.82--1.302X^2^ *p* = 0.31Carbon black productionNoRR 1.10; 95 % CI 0.61--2.003X^2^ *p* = 0.29Egger *p* = 0.61Workers in iron and steel foundryNoRR 1.38; 95 % CI 1.00--1.919X^2^ *p* = 0.001Egger *p* = 0.3*95* *% CI* 95 % confidence interval, *CC* case--control study, *C-COH* case-cohort study, *COH* cohort study, *df* degrees of freedom, *ECO* ecological study, *HCC* hospital-based case--Control study, *Het.* heterogeneity, *Hom.* homogeneity, *NCC* nested case--control study, *N.S.* not significant, *OR* odds ratio, *PCC* population-based case--control study, *PCOH* prospective cohort study, *PMR* proportional mortality ratio, *RCOH* retrospective cohort study, *RE* risk estimate, *RCT* randomised controlled trial, *RL* record linkage study, *RR* relative risk, *SIR* standardised incidence ratio^\$^The *p* value was calculated by the authors of the current article when only the *X* ^2^ statistic and degrees of freedom were presented

Appendix 3 {#Sec53}
==========

See Table [4](#Tab4){ref-type="table"}.Table 4Risk estimates for occupations reported by Cumberbatch et al., Reulen et al., Kogevinas et al., and 't Mannetje et alCumberbatch et al. \[53\] (Meta-analysis of 217 studies)Reulen et al. \[62\]\
(Meta-analysis of 66 cohort studies and 64 case--control studies)Kogevinas et al. \[63\]\
(Pooled analysis of 11 European CC studies)'t Mannetje et al. \[64\]\
(Pooled analysis of 11 European CC studies)OccupationRRs (95 % CI)OccupationRRs (95 % CI)Occupations (ISCO code\*)\[[@CR183]\]RR (95 % CI)Occupations (ISCO codes)RR (95 % CI)*Occupations with statistically significant results*Tobacco workers1.72 (1.37--2.15)Blacksmiths1.58 (1.05--2.36)Working proprietors---wholesale and retail trade (41)1.33 (1.04--1.69)Blacksmiths, toolmakers and machine-tool operators (83)1.9 (1.1--3.6)Dye workers1.58 (1.32--1.90)Blacksmiths and tool-makers1.22 (1.09--1.35)Working proprietor---retail trade (41030)1.35 (1.02--1.79)Lathe operator (83420)4.6 (1.1--19.2)Chimney sweeps1.53 (1.30--1.81)Building finishers1.16 (1.02--1.33)Working proprietor---cafe. bar and snack bar (51050)2.2 (1.16--4.20)Blacksmiths, toolmakers and machine-tool operators nec. (839)2.9 (1.3--6.3)Nurses1.49 (1.06--2.08)Domestic helpers1.39 (1.14--1.70)Concierge---apartment house (55120)2.64 (1.10--6.32)Field crop and vegetable farm workers (622)1.8 (1.0--3.1)Rubber workers1.49 (1.37--1.61)Dye makers1.14 (1.09--1.19)Janitor (55130)2.28 (1.30--3.98)Tobacco prepares and tobacco product makers (78)3.1 (1.1--9.3)Waiters1.43 (1.34--1.52)Furnace operators1.41 (1.11--1.79)Nursery workers and gardeners (627)1.5 (1.07--2.10)Tailors and dressmakers (791)1.4 (1.0--2.1)Aluminum workers1.41 (1.29--1.55)Glass-makers1.69 (1.13--2.52)Other nursery workers and gardeners (62790)3.57 (1.24--10.29)Other saleswomen, shop assistants and demonstrators (45190)2.6 (1.0--6.9)Hairdressers1.32 (1.24--1.40)Launderers1.72 (1.25--2.37)Supervisor and general foreman---metal processing---(70030)2.11 (1.04--4.32)Mail sorting clerk (37020)4.4 (1.0--19.5)Printers1.23 (1.17--1.30)Leather workers1.37 (1.10--1.70)Supervisor and general foreman---manufacturing of machinery and metal products (70050)1.59 (1.05--2.42)Seamen1.23 (1.17--1.29)Machine-tool setters1.31 (1.12--1.53)Miners, quarrymen, well drillers and related workers (71)1.26 (1.00--1.58)Oil and petroleum workers1.2 (1.06--1.37)Machinist1.16 (1.04--1.29)Miners and quarrymen (711)1.3 (1.02--1.64)Shoe and leather workers1.2 (1.12--1.29)Mechanics1.20 (1.06--1.35)Metal casters (724)1.96 (1.06--3.64)Plumbers1.2 (1.14--1.27)Metal processors1.24 (1.11--1.38)Metal processers NEC (729)1.85 (1.15--2.97)Sales agents1.17 (1.15--1.20)Metal workers1.15 (1.01--1.32)Knitters (755)2.56 (1.24--5.30)Artistic workers1.16 (1.10--1.22)Miners1.57 (1.21--2.03)Knitting-machine operator-hosiery (75530)3.26 (1.26--8.40)Cooks and stewards1.15 (1.08--1.22)Motor mechanics1.39 (1.11--1.73)Metal workers and machinists (832--835, 841, 849)1.16 (1.02--1.32)Chemical process workers1.14 (1.10--1.19)Paper-pulp workers1.29 (1.02--1.63)Machine-tool setter-operators (833)1.5 (1.07--2.12)Metal workers1.14 (1.11--1.18)Rubber workers1.43 (1.18--1.71)Metalworking machine setter---general (83305)2.27 (1.03--5.00)Drivers1.14 (1.11--1.16)Writers and artists1.34 (1.06--1.71)Metalworking machine setter-operator---general---(83310)3.35 (1.19--9.44)Fishermen1.13 (1.08--1.19)Precision-grinding-machine setter-operator---(83370)5.21 (1.48--18.31)Painters1.13 (1.09--1.17)Machinery fitters, machine assemblers and precision-instrument makers---except electrical (84)1.16 (1.01--1.34)Assistant nurses1.12 (1.04--1.20)Automobile mechanic (84320)1.38 (1.02--1.87)Domestic assistants1.12 (1.07--1.18)Machinery fitters, machine assemblers and precision-instrument makers---except electrical---NEC (849)1.27 (1.03--1.55)Launderers and dry cleaners1.12 (1.04--1.21)Textile machinery mechanic (84945)2.86 (1.50--5.47)Public safety workers--police1.11 (1.07--1.16)Other electrical fitters (85190)3.99 (1.10--14.51)Physicians1.11 (1.03--1.19)Electric arc welder---hand (87220)2.27 (1.04--4.98)Clerical workers1.11 (1.10--1.13)Printers and related workers (92)1.45 (1.07--1.97)Electrical workers1.11 (1.07--1.14)Printing pressmen (922)1.81 (1.03--3.17)Military personnel1.11 (1.05--1.18)Automobile painter (93960)1.95 (1.01--3.75)Mechanics1.11 (1.09--1.13)Excavating-machine operator (97420)2.43 (1.18--5.00)Smelting workers1.11 (1.06--1.16)Transport equipment operators (98)1.17 (1.02--1.34)Transport workers1.1 (1.06--1.13)Glass makers, etc.1.1 (1.05--1.15)Textile workers1.1 (1.06--1.14)Waiters and bartenders1.1 (1.01--1.19)Building caretakers1.09 (1.06--1.13)Health care workers1.09 (1.06--1.12)Food manufacturing workers1.08 (1.04--1.12)Postal workers1.08 (1.03--1.13)Packers, loaders, and warehouse workers1.08 (1.04--1.13)Shop workers1.07 (1.05--1.10)Technical workers, etc.1.04 (1.02--1.06)Economically inactive0.96 (0.95--0.97)Religious and legal workers, etc.0.93 (0.88--0.97)Forestry workers0.88 (0.86--0.90)Teachers0.85 (0.82--0.87)Gardeners0.78 (0.75--0.81)Farmers0.69 (0.68--0.71)*Occupations with no statistically significant results*Beverage workers1.35 (0.84--2.16)Architects and engineers0.99 (0.85--1.16)Medical doctors (061)0.82 (0.40--1.69)Hairdressers, barbers, beauticians and related workers (57)0.8 (0.4--1.7)Iron and metal ware workers1.18 (0.98--1.42)Armed forces1.09 (0.90--1.33)Nurses (071--079)0.89 (0.51--1.56)Chemical processors and related workers (74)0.6 (0.2--2.2)Other health workers1.11 (0.97--1.27)Bakers1.02 (0.54--1.92)Teachers (13)1 (0.74--1.34)Spinners, weavers, knitters, dyers and related workers (75)0.9 (0.6--1.3)Dentists1.09 (0.96--1.23)Bricklayers1.15 (0.96--1.38)Salesmen, shop assistants (45)0.97 (0.82--1.14)Shoe makers and leather goods makers (80)0.4 (0.2--1.1)Welders1.06 (1.00--1.12)Building caretakers1.26 (0.88--1.80)Cooks, waiters, bartenders (53)1..19 (0.91--1.55)Metal working including toolmakers, machine-tool setter-operators, metal grinders and machinery fitters (832--835, 841, 849)1.5 (0.8--2.7)Bricklayers1.05 (0.99--1.12)Building frame workers1.08 (0.93--1.26)Launderers, dry-cleaners and pressers (56)1.24 (0.67--2.31)Rubber and plastics product makers (90)1.2 (0.5--3.0)Miners and quarry workers1.05 (1.00--1.11)Butchers1.38 (0.88--2.18)Hairdressers (57)1.09 (0.70--1.70)Laboratory assistants1.04 (0.92--1.18)Cabinet makers0.98 (0.58--1.67)Fire-fighters (581)0.66 (0.27--1.62)Mixed occupations1.02 (1.00--1.04)Carpenters1.04 (0.80--1.35)Farmers (61)0.94 (0.77--1.14)Public safety workers--firefighters1.00 (0.90--1.12)Cleaners1.25 (0.86--1.80)Production supervisors and general foremen (70)1.1 (0.89--1.37)Other construction workers0.98 (0.96--1.00)Clerks0.92 (0.83--1.02)Metal processers (72)1.14 (0.93--1.39)Engine and motor operators0.91 (0.55--1.51)Cooks1.13 (0.93--1.38)Sawyers, plywood makers and related wood-processing workers (732)1.51 (0.91--2.48)Other workers0.48 (0.13--1.80)Electricians1.04 (0.87--1.24)Chemical processors (74)1.09 (0.82--1.45)Firefighters1.26 (0.76--2.09)Petroleum-refining workers (745)0.52 (0.10--2.69)Fishery workers0.81 (0.62--1.06)Textile workers (75)1.05 (0.81--1.36)Food processors1.03 (0.90--1.18)Butchers and meat preparers (773)0.99 (0.70--1.41)Forestry workers1.00 (0.80--1.24)Food preservers (774)1.07 (0.34--3.32)Freight handlers1.10 (0.94--1.28)Dairy product processers (775)1.26 (0.61--2.60)Gardeners1.19 (0.84--1.70)Tailors, dressmakers, sewers, upholsterers (79)1.07 (0.77--1.49)Hand packers0.99 (0.70--1.41)Leather workers (801--803)1.31 (0.89--1.94)Health professionals1.07 (0.87--1.31)Motor-vehicle mechanics (843)1.16 (0.90--1.50)Managers1.39 (0.95--2.03)Electrical fitters and related electrical and electronics workers (85)1.1 (0.91--1.34)Nurses0.90 (0.44--1.85)Plumbers (871)0.98 (0.69--1.39)Plumbers1.23 (0.97--1.56)Welders (872)1.22 (0.91--1.63)Police officers and guards1.03 (0.78--1.36)Rubber workers (901, 902)1.18 (0.84--1.67)Printers1.10 (0.87--1.40)Paper and paperboard product makers (91)0.96 (0.41--2.24)Protective service occupations0.94 (0.84--1.05)Painters (93)1.17 (0.91--1.50)Sheet metal workers1.09 (0.57--2.07)Asbestos cement product maker (94330)0.64 (0.16--2.49)Tailors1.33 (0.93--1.90)Reinforced concreters, cement finishers and terrazzo workers (952)1.17 (0.86--1.59)Teaching professionals0.98 (0.70--1.37)Roofers (953)0.72 (0.36--1.43)Tool-makers1.17 (0.86--1.59)Carpenters, joiners and parquetry workers (954)1.04 (0.81--1.34)Welders1.04 (0.88--1.23)Plasterers (955)1.69 (0.84--3.41)Insulators (956)1.67 (0.61--4.59)Construction workers NEC (959)0.88 (0.68--1.16)Stationary engine and related equipment operators (96)1.07 (0.72--1.57)Railway engine-drivers and firemen (983)1.41 (0.87--2.28)Railway brakemen, signalmen and shunters (984)1.43 (0.77--2.63)Motor vehicle drivers (985)1.14 (0.97--1.33)Industries (ISIC code^\$^) \[[@CR184]\]Salt mining (2903)4.41 (1.43--13.6)Manufacture of carpets and rugs (3214)4.07 (1.44--11.5)Manufacture of paints, varnishes and lacquers (3521)2.94 (1.48--5.84)Manufacture of plastic products NEC (356)1.79 (1.06--3.00)Manufacture of industrial chemicals (351)1.58 (1.07--2.33)Education services (931)1.47 (1.06--2.05)\* ISCO (International Standard Classification of Occupations); ^\$^ ISIC (International Standard Industrial Classification)
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